News

Study Suggests HUD's New Smoke-Free Policy Will Help More Low-Income Smokers Quit

Enforcing residential bans on smoking could help large numbers of low-income people quit smoking, according to an analysis of federally funded national surveys by a California research team. The finding comes as public housing authorities across the country face a July 31st deadline from the U.S

Genomic Landscape of Metastatic Prostate Cancer Unveiled in New Study

A comprehensive genetic analysis of metastatic prostate cancer has, for the first time, revealed a number of major ways in which abnormal alterations of the genome propel this aggressive form of the disease. As reported in the July 19, 2018 issue of Cell, a team led by investigators at UC San

NIH and Prostate Cancer Foundation Launch Large Study on Aggressive Prostate Cancer in African-American Men

UCSF is one of four NCI cancer centers leading a large national study of African American men with aggressive prostate cancer. The RESPOND study, which will examine links between aggressive disease and environmental and genetic factors, aims to enroll 10,000 men. The following press release was

Breast Cancer Follow-Up Imaging Varies Widely, Study Finds

Follow-up imaging for women with non-metastatic breast cancer varies widely across the country, according to a new study led by researchers at UC San Francisco. Some patients go without the annual mammograms that experts recommend, while others with the same cancer diagnosis receive full-body scans

Investigator Celebrates Collaboration and the 'X' in Cancer Research at UCSF

Successful cancer centers like the HDFCCC place a premium on interdisciplinary collaboration. With labs, clinics and offices spread among three UCSF campuses, leadership and members continually devise ways to overcome the geographic separation. Jeroen Roose, co-leads the Parnassus Cancer Research

T Cell Engineering Breakthrough Sidesteps Need for Viruses in Gene-Editing

In an achievement that has significant implications for research, medicine, and industry, UC San Francisco scientists have genetically reprogrammed the human immune cells known as T cells without using viruses to insert DNA. The researchers said they expect their technique—a rapid, versatile, and

Deadly Form of Advanced Prostate Cancer Is Common, Calls for Distinct Treatment

A new study of prostate cancer in 202 men, whose cancers had spread and were resistant to standard treatment, found that a surprisingly large number of these cancers – about 17 percent – belong to a deadlier subtype of metastatic prostate cancer. Previously, it was thought that these cancers